In-Licensing Considerations for Life Sciences Startups

11:00 am – 12:00 pm PT
1:00 – 2:00 pm CT
2:00 – 3:00 pm ET

This panel discussion will explore key considerations for companies that are in-licensing biotech or pharmaceutical technologies. Panelists will discuss the top factors that drive value in a licensing deal, including how to structure IP arrangements to advance your goals.

Topics include:

• Exploring different paths to licensing
• How to structure the licensing agreement to enhance value
• Patent due diligence and contemplating co-ownership of patents

Speakers

• Nena Golubovic – Managing Director, IP Group
• Lila Hope – Partner, Cooley
• Amy Baker Mandragouras – Partner, Cooley
• Michael Salgaller – Technology Transfer Center, National Institutes of Health
• Shawn Yu – Associate, Cooley (Moderator)

Details and registration

For more information, please email Seema Desai.